Clinical Trial Update: Fentanyl Sublingual Spray for the Treatment of Acute Procedure-related Pain in a Monitored Setting [Phase 3]

View source ↗

Summary

Phase 3 trial of fentanyl sublingual spray for acute procedure-related pain in a monitored setting was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• fentanyl sublingual spray (fentanyl)

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Chronic Pain | Phase 3 | Status: WITHDRAWN